Related Experiment Videos

Hepatitis B x protein inhibits p53-dependent DNA repair in primary mouse hepatocytes

S Prost1, J M Ford, C Taylor

  • 1Department of Pathology, University Medical School, Teviot Place, Edinburgh EH8 9AG, Scotland. s.prost@ed.ac.uk

Insights

Hepatitis B virus X protein (HBx) impairs DNA repair in liver cells. This impairment is p53-dependent, potentially contributing to liver cancer development by accumulating genetic damage.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Cancer Research

Background:

  • Hepatitis B virus X protein (HBx) is implicated in liver cancer (hepatocarcinogenesis).
  • HBx may contribute to cancer by interfering with the tumor suppressor p53 and its DNA repair functions.
  • The precise mechanisms of HBx-induced DNA repair inhibition are not fully understood.

Purpose of the Study:

  • To investigate the role of p53 in DNA repair in hepatocytes.
  • To determine how HBx affects nucleotide excision repair (NER) in liver cells.
  • To elucidate the p53-dependent mechanisms by which HBx may promote hepatocarcinogenesis.

Main Methods:

  • Assessed global genomic repair and transcription-coupled repair of DNA damage (cyclobutane pyrimidine dimers and 6-4 photoproducts) in wild-type and p53-null mouse hepatocytes.
  • Expressed HBx in hepatocytes to evaluate its impact on DNA repair.
  • Compared DNA repair efficiency in different cell types and under various experimental conditions.

Main Results:

  • Mouse hepatocytes exhibit efficient global repair of cyclobutane pyrimidine dimers, comparable to human cells.
  • p53 is essential for global genomic DNA repair of cyclobutane pyrimidine dimers but not for transcription-coupled repair.
  • HBx expression reduces global DNA repair in a p53-dependent manner, lowering repair levels in wild-type cells to those of p53-null cells.

Conclusions:

  • Hepatitis B virus X protein inhibits the p53-dependent component of global DNA repair in hepatocytes.
  • This inhibition can lead to the accumulation of genetic defects over time, potentially fostering liver cancer development.
  • Targeting HBx-mediated DNA repair inhibition could be a strategy for preventing hepatitis B virus-associated liver cancer.

Related Concept Videos